209 related articles for article (PubMed ID: 30362976)
1. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.
Abdel-Rahman O
Melanoma Res; 2019 Feb; 29(1):53-58. PubMed ID: 30362976
[TBL] [Abstract][Full Text] [Related]
2. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
[TBL] [Abstract][Full Text] [Related]
3. Population-based assessment of the National Comprehensive Cancer Network recommendations for baseline imaging of rectal cancer.
Abdel-Rahman O; Cheung WY
J Comp Eff Res; 2019 Oct; 8(14):1167-1172. PubMed ID: 31638428
[No Abstract] [Full Text] [Related]
4. Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?
Abdel-Rahman O
J Comp Eff Res; 2019 Feb; 8(3):157-163. PubMed ID: 30624081
[TBL] [Abstract][Full Text] [Related]
5. Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma.
Abdel-Rahman O; Cheung WY
Med Oncol; 2019 Feb; 36(3):26. PubMed ID: 30707324
[TBL] [Abstract][Full Text] [Related]
6. Is routine baseline brain imaging needed for all newly diagnosed non-small-cell lung cancer patients?
Abdel-Rahman O
J Comp Eff Res; 2019 Jun; 8(8):569-575. PubMed ID: 31116030
[No Abstract] [Full Text] [Related]
7. Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients.
Ribuffo D; Cavalieri L; De Vita F; Massa R; Prosperi D; Tuccimei M; Scuderi N
J Exp Clin Cancer Res; 2001 Mar; 20(1):11-5. PubMed ID: 11370816
[TBL] [Abstract][Full Text] [Related]
8. North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients.
Preisser F; Mazzone E; Nazzani S; Marchioni M; Bandini M; Tian Z; Saad F; Soulières D; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
Br J Cancer; 2018 Dec; 119(12):1552-1556. PubMed ID: 30425350
[TBL] [Abstract][Full Text] [Related]
9. Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis.
Abdel-Rahman O
J Dermatolog Treat; 2018 Mar; 29(2):176-181. PubMed ID: 28745581
[TBL] [Abstract][Full Text] [Related]
10. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
11. [Computed tomography evaluation of metastasis of cutaneous melanoma].
Potente G; Cantisani C; Cantisani V; Bottoni U; Calvieri S; Andreoli GM; Arduini F; Guerrisi R
Radiol Med; 2001 Apr; 101(4):275-80. PubMed ID: 11398059
[TBL] [Abstract][Full Text] [Related]
12. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
Tas F; Erturk K
Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
[TBL] [Abstract][Full Text] [Related]
13. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
14. Preoperative nuclear scans in patients with melanoma.
Au FC; Maier WP; Malmud LS; Goldman LI; Clark WH
Cancer; 1984 May; 53(10):2095-7. PubMed ID: 6704898
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
[TBL] [Abstract][Full Text] [Related]
16. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
17. Scintiscans in the evaluation of patients with malignant melanomas.
Thomas JH; Panoussopoulous D; Liesmann GE; Jewell WR; Preston DF
Surg Gynecol Obstet; 1979 Oct; 149(4):574-6. PubMed ID: 483138
[TBL] [Abstract][Full Text] [Related]
18. Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER-based study.
Qiu MZ; Shi SM; Chen ZH; Yu HE; Sheng H; Jin Y; Wang DS; Wang FH; Li YH; Xie D; Zhou ZW; Yang DJ; Xu RH
Cancer Med; 2018 Aug; 7(8):3662-3672. PubMed ID: 29984918
[TBL] [Abstract][Full Text] [Related]
19. Radionuclide scanning in patients with advanced malignant melanoma.
Muss HB; Richards F; Barnes PL; Willard VV; Cowan RJ
Clin Nucl Med; 1979 Dec; 4(12):516-8. PubMed ID: 527290
[TBL] [Abstract][Full Text] [Related]
20. Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute.
Katz KA; Jonasch E; Hodi FS; Soiffer R; Kwitkiwski K; Sober AJ; Haluska FG
Melanoma Res; 2005 Feb; 15(1):77-82. PubMed ID: 15714125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
